ISRCTN15834472进行中（未招募）未知
Efficacy and safety of Twin Precision treatment protocol on hypertension- an open label randomised controlled trial
Twin Health0 个研究点目标入组 312 人开始时间: 2021年5月13日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 312
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Patients between 18 to 70 years of age
- •2. On treatment for hypertension (monotherapy or multiple drugs)
排除标准
- •1. Uncontrolled hypertension (>180/110 mm/Hg) or history of hypertensive emergency requiring admission
- •2. Hypertension due to secondary causes
- •3. Diabetes mellitus
- •4. Heart failure with EF <45%
- •5. eGFR less than 60 ml/min/1.73 m²
- •6. Any major cardiovascular event in the last 12 months (such as MI, stroke, TIA)
研究者
相似试验
尚未招募
不适用
Twin enabled diet intervention for reversing hypertensioCTRI/2021/01/030797Twin Health
招募中
不适用
Efficacy and safety of Twin Precision treatment in patients with hypertensioCTRI/2022/05/042752TWINS DIGITAL SERVICES INDIA PRIVATE LIMITED
进行中（未招募）
不适用
Blood pressure reduction in patients with high blood pressure (hypertension) with diet and lifestyle modificatioCirculatory SystemHypertensionISRCTN17705472Twin Health300
进行中（未招募）
不适用
Effects of nutrition in diabetic/non-diabetic participants who have increased fat in the liveron-alcoholic fatty liver disease (NAFLD)Digestive SystemFatty (change of) liver, not elsewhere classifiedISRCTN11412541TWINS Digital Services India pvt ltd79
招募中
4 期
Clinical effectiveness of 2 treat to target strategies, mimicking standard care compared to early secukinumab for the treatment of Moderate to Severe Psoriatic arthritis: a parallel group randomised controlled trial.psoriatic arthritisNL-OMON55356Erasmus MC, Universitair Medisch Centrum Rotterdam120